Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.98 USD | +0.50% | -2.12% | +16.31% |
May. 22 | Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing | MT |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |